Clinical Trials Logo
  1. Home
  2. Rheumatoid Arthritis
  3. NCT06134726
  4. Details
NCT06134726 Clinical Trial

Temporomandibular Joint in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis Clinical Trial

Official title:
Temporomandibular Joint in Patients With Rheumatoid Arthritis

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT06134726
Other study ID # BX63413,2021
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 15, 2021
Est. completion date January 15, 2023

Study information
Verified date November 2023
Source Syrian Private University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

the investigators study aimed to evaluate temporomandibular joint involvement in rheumatoid arthritis patients and healthy individuals 142 participants were recruited in two groups: 72 patients with Rheumatoid Arthritis (RA), and 70 healthy controls. All participants were tested for seropositivity of rheumatoid factor and anticitrullinated protein antibodies. TMD diagnosis was determined according to the standardized and validated diagnostic criteria for TMD (DC/TMD): myalgia, arthralgia, articular disc, displacement, degenerative joint disease, and headache attributed to TMD. Bruxism, a probable sleep and/or awake bruxism diagnosis was determined based on self-report and several clinical findings.

Recruitment information / eligibility
Status Completed
Enrollment 142
Est. completion date January 15, 2023
Est. primary completion date January 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 35 Years to 50 Years
Eligibility - Inclusion criteria included: - age > 18 years old - individuals who had a minimum of 12 natural teeth. - Exclusion criteria - included: trauma or surgery on the jaw - facial nerve paralysis - tooth implant - scleroderma - cerebrovascular accident - schizophrenia - steroid injection within the last six months.

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• seropositivity of rheumatoid factor
All participants were tested for seropositivity of rheumatoid factor and anticitrullinated protein antibodies

Locations
Country Name City State
Syrian Arab Republic Faculty of Medicine, Damascus University, Syria Damascus

Sponsors (1)
Lead Sponsor Collaborator
Syrian Private University

Country where clinical trial is conducted

Syrian Arab Republic, 

Outcome
Type Measure Description Time frame Safety issue
Primary Number of patients with prevalence of TMD patients were interviewed, filled out the questionnaire, and examined 2 years
Primary Number of patients with TMD-pain diagnoses patients were interviewed, filled out the questionnaire, and examined 2 years
See also
  Status Clinical Trial Phase
Completed NCT04226131 - MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics N/A
Completed NCT04171414 - A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis Phase 3
Completed NCT02833350 - Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) Phase 2
Completed NCT04255134 - Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN) Phase 4
Recruiting NCT05615246 - Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Completed NCT03248518 - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases N/A
Completed NCT03514355 - MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms N/A
Recruiting NCT06005220 - SBD121, a Synbiotic Medical Food for RA Management N/A
Recruiting NCT05451615 - Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis Phase 3
Completed NCT05054920 - Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis N/A
Completed NCT02037737 - Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting N/A
Recruiting NCT04079374 - Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel Phase 3
Completed NCT02504268 - Effects of Abatacept in Patients With Early Rheumatoid Arthritis Phase 3
Recruiting NCT05496855 - Remote Care in People With Rheumatoid Arthritis N/A
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Recruiting NCT06031415 - Study of GS-0272 in Participants With Rheumatoid Arthritis or Systemic Lupus Erythematosus Phase 1
Recruiting NCT06103773 - A Study of Single and Multiple Oral Doses of TollB-001 Phase 1
Completed NCT05999266 - The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
Recruiting NCT05302934 - Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
Recruiting NCT04169100 - Novel Form of Acquired Long QT Syndrome Phase 4